Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response: UK study

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday (Dec 6). \u0022We found a really good immune response ac

LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday .

"I think the data from this study will be especially interesting and valuable to low- and middle-income countries where they're still rolling out the first two doses of vaccines," Snape said. The study of 1,070 volunteers also found that a dose of the Pfizer-BioNTech vaccine followed by a Moderna shot was better than two doses of the standard Pfizer-BioNTech course.

Many countries have been deploying a mix and match well before robust data was available as nations were faced with soaring infection numbers, low supplies and slow immunisation over some safety concerns.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Jmm gggjffjfhf

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022KIGALI: South Africa\u0027s Biovac Institute will start making Pfizer-BioNTech\u0027s COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday (Dec 6). That earlier than the forecast start at around the second half of 2022 given by Cape Town-bas
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Australia's medicine regulator approves Pfizer vaccine for children aged 5 to 11MELBOURNE: Australia\u0027s medicine regulator provisionally approved on Sunday (Dec 5) the Pfizer coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan 10. \u0022They (the Therapeutics Goods Administration) have made a careful, thor , I'm M y u BB uhh be avvt K vy boK
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022KIGALI: South Africa\u0027s Biovac Institute will start making Pfizer-BioNTech\u0027s COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday (Dec 6). That earlier than the forecast start at around the second half of 2022 given by Cape Town-bas
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

UBS gives Hong Kong staff COVID-19 quarantine cashHONG KONG: UBS Group has offered its Hong Kong staff up to HK$2,000 (US$256.45) a day to help cover mandatory hotel quarantine costs as the city maintains some of the strictest COVID-19 restrictions in the world. In a memo seen by Reuters, the bank said full-time employees up to executive director level wo
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

MOM: Non-Malaysian work permit or S pass holders in CMP sectors can no longer enter S’pore via VLT - The Independent Singapore NewsIn response to the Omicron Covid-19 variant, Singapore announced on Friday stricter rules for VTL travellers. in responed 2 all inquiree..i believd izs fair MOM hab 2 take such steps in d domitree issues..
Source: IndependentSG - 🏆 2. / 72 Read more »


Source: BusinessTimes - 🏆 15. / 51 Read more »